Cumberland Pharmaceuticals Inc.
CPIX
$2.28
$0.125.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -23.48% | -7.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -23.48% | -7.48% | |||
| Cost of Revenue | -50.84% | 41.08% | |||
| Gross Profit | -17.25% | -14.20% | |||
| SG&A Expenses | -1.31% | 6.03% | |||
| Depreciation & Amortization | 0.31% | 0.12% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.46% | 11.17% | |||
| Operating Income | -162.92% | -157.86% | |||
| Income Before Tax | -166.40% | -158.18% | |||
| Income Tax Expenses | 0.00% | 0.00% | |||
| Earnings from Continuing Operations | -165.10% | -158.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 250.91% | -161.80% | |||
| Net Income | -162.02% | -158.92% | |||
| EBIT | -162.92% | -157.86% | |||
| EBITDA | -423.85% | -87.67% | |||
| EPS Basic | -162.02% | -158.86% | |||
| Normalized Basic EPS | -161.69% | -158.11% | |||
| EPS Diluted | -160.00% | -162.50% | |||
| Normalized Diluted EPS | -161.69% | -159.34% | |||
| Average Basic Shares Outstanding | -0.01% | 0.12% | |||
| Average Diluted Shares Outstanding | -0.01% | -1.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||